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A NUMBER of metals and some of their compounds have shown evidence of
carcinogenic activity in the experimental animal and a briefreview ofthese agents
has been given by Roe and Lancaster (1964). One metal currently receiving
attention in this respect has been cadmium. The repeated subcutaneous injection
of ferritin in a group of rats was found to produce malignant tumours at the
injection site, testicular atrophy and interstitial cell tumours ofthe testis (Haddow,
Dukes and Mitchley, 1]961). The ferritin had been prepared from rat-liver
protein by precipitation with a cadmium salt. Following this observation similar
results were obtained in a group of rats given repeated injections of a soluble
cadmium salt in the form of cadmium sulphate. (Haddow, Roe, Dukes and
Mitchley, 1964; Roe, Dukes, Cameron, Pugh and Mitchley, 1964) Sarcomata
at the injection site and testicular tumours were later reported following the single
subcutaneous injection of a relatively small dose of cadmium chloride, another
soluble compound (Gunn, Gould and Anderson, 1964). Finely divided cadmium
metal suspended in serum and injected into the thigh muscle of the rat led to
the production of rhabdomyosarcoma and fibrosarcoma in an experiment given
in a preliminary report by Heath, Daniel, Dingle and Webb (1962), and described
in detail by Heath and Daniel (1964). The insoluble compound cadmium sulphide
has also been shown to give rise to sarcomata at the site of subcutaneous injection
in the rat (Kazantzis, 1963). The results of this experiment, performed indepen-
dently in 1961, together with the findings in a further series, are now given in
detail. The induction of sarcomata at the site of subcutaneous injection of
cadmium sulphide was confirmed, and similar tumours were shown to follow
intramuscular injection. However, the intratracheal instillation of cadmium
sulphide was not followed by the development of tumours, although there were
other pathological changes which will be reported separately. In a further
experiment a high incidence oftumours was obtained at the injection site following
the subcutaneous injection of a suspension of cadmium oxide.
MATERIALS AND METHOD
Wistar rats of the Chester Beatty strain were used. They were provided
with water and with pellets of diet 41B (Medical Research Council) ad libitum.
A standardised vitamin supplement was added, and the diet supplemented at
intervals with liver, bread and milk. The animals were lightly anaesthetised with
ether and the skin at the injection site was shaved and cleaned with spirit. A
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suspension ofthe cadmium compound was made in physiological saline and injected
with a mantoux syringe fitted with a 20 gauge needle. The injection was made
2-3 cm. from the site of skin puncture to obviate loss of the injected material
through the needle track.
Cadmium sulphide used in the experiments was prepared in the laboratory from
AR grade cadmium sulphate (3CdSO4.8H20) acidified with 0-25 molar hydro-
chloric acid, and from hydrogen sulphide, produced in a Kipp's apparatus. The
precipitate of cadmium sulphide obtained in this way was filtered, washed
repeatedly, dried and ground to produce a fine yellow powder. The particles of
cadmium sulphide seen in tissue sections were of the order of 0-5 It diameter, but
much of the material was aggregated into larger masses. An X-ray diffraction
pattern of the cadmium sulphide powder showed some defects in the crystalline
structure of the material. Sulphate ion could not be detected in a sample of
cadmium sulphide on testing with barium chloride.
The cadmium oxide used was GPR grade (Hopkin & Williams Ltd.). The
specification of this material was cadmium oxide 99% minimum, sodium and
potassium 0.0500 maximum, iron 0.001% maximum, chloride 0.01% and sulphate
0.02% maximumii.
Tissues for histological examination were fixedinformolsaline, stainedroutinely
with haematoxylin and eosin and, where appropriate, with Mallory's phosphotung-
stic acid haematoxylin and with Van Gieson's stain.
Induction of sarcoma at the site of subcutaneous injection of cadmium sulphide
An injection of 25 mg. cadmium sulphide suspended in 0-25 ml. physiological
saline was given into the dorsal subcutaneous tissue on either side of the midline,
on a single occasion, in 10 six-month old female rats weighing between 230 g. and
325 g. No ill effects appeared to follow the injection, but a soft, oedematous
swelling developed at the injection site which gradually subsided after some days
to leave a small, hard nodule. Six months after injection one ofthe nodules began
to grow in size until a large tumour developed in the flank of one of the animals.
Subsequently, similar large tumours developed in 5 further rats giving a total of 6
rats with growing tumours out of the group of 10 which had been injected.
These 6 animals died or were killed within one year from the time of injection,
when the tumours had grown to 3 to 6 cm. in diameter. Of the remaining 4
animals in the series which did not develop growing tumours, 3 died 8 months after
injection and one died 12 months after injection, so that there were no survivors
after one year. Table I shows the time of survival after injection and the animals
which developed tumours.
The tumours were coarsely lobulated, with a firm to hard consistency. The
cut surfaces were pale pink with pearly grey areas and showed foci of the bright
yellow injected pigment. The tumours were growing into the body wall so that
swellings were visible from the serosal surface (Fig. 1). In one case (Rat 7) the
kidney had been displaced forwards by the tumour, but the peritoneal surface had
not been breached. In another case (Rat 6) the abdominal wall had been pene-
trated and the tumour had disseminated widely over the peritoneal cavity and
omentum. Axillary, posterior thoracic or abdominal lymph nodes were enlarged
in all 6 animals. Histological examination showed the tumours to be highly
cellular, with some poorly formed vascular spaces and areas of degeneration,
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haemorrhage and necrosis. In some parts, spindle cells predominated, arranged
in interlacing bundles with collagen fibres between the cells (Fig. 2). In other
parts the cells were large, pleomorphic and bizarre in shape with large hyper-
chromatic nuclei (Fig. 3). No definite evidence of cytoplasmic cross-striation
was seen in the sections stained with phosphotungstic acid haematoxylin. Multi-
nucleate giant cells were present, more numerous in some sections than in others.
Many cells contained mitotic figures and many abnormal mitoses were seen where
the chromatin material was fragmented and scattered in the cytoplasm. Van
Gieson stained sections showed the presence of collagen (Fig. 4) which varied in
amount in different tumours and in different parts of the same tumour. In some
sections only fine arborisations of collagen were seen between closely packed cells.
Particles which had the appearance of the injected cadmium sulphide were scat-
tered in the tumour tissue, some being free and others intracellular. The larger
clumps of pigment were clearly doubly refractile. Spindle cells and pleomorphic
cells were seen infiltrating the connective tissue and muscle of the chest and
abdominal wall, isolating segments of striped muscle into small islands. Meta-
static deposits with cells similar in appearance to the cells in the primary tumours
were seen in the regional lymph nodes (Rats 4, 5, 6, 7). The lungs in Rats 4 and
6 also contained metastases (Fig. 5). In Rat 6, deposits of tumour cells were
found on the surface of the spleen, stomach and pancreas. In Rat 9, a large
tumour developed in the left flank and a smaller swelling, 1 cm. in diameter at
the time the animal was killed, had developed at the second injection site in the
right flank. Microscopic examination of the second swelling showed a deposit of
pigment surrounded by a granulomatous reaction and dense fibrosis, and in places
there were plump spindle cells with irregular nuclei and mitoses.
The tumours in the 6 rats were considered to be examples of cellular, spindle-
celled and pleomorphic-celled fibrosarcoma.
Rat 5, subcutaneous CdS (1961 series).-The animal was killed 10 months
after injection. The skin was reflected off a large tumour on the back to expose
a lobulated, hard mass, pinky grey with a yellow area, similar in colour to the
injected material. The tumour bulged into the pleural and peritoneal cavities,
EXPLANATION OF PLATES
FIG. 1. Subcutaneous CdS: Gross appearance of tumour.
FIG. 2.-Subcutaneous CdS: Spindle cell fibrosarcoma. H. & E. x 520.
FIG. 3.-Subcutaneous CdS: Pleomorphic sarcoma. H. & E. x 610.
FIG. 4.-Subcutaneous CdS: Sarcoma stained to show collagen. V.G. x 290.
FIG. 5. Subcutaneous CdS: Metastatic deposit of tumour tissue in lung. H. & E. x 50.
FIG. 6.- Subcutaneous CdS: Rat killed 48 hours after injection. CdS deposit in subcutaneous
tissue with associated inflammatory response. H. & E. x 75.
FIG. 7. Subcutaneous CdS: Rat killed 4 days after injection. Acute inflammatory reaction
with early fibroblastic response. H. & E. x 75.
FIG. 8. Subcutaneous CdS: Rat killed 3 months after injection. Fibrous tissue in relation
to deposited pigment. H. & E. x 75.
FIG. 9. Subcutaneous CdS: Pleomorphic sarcoma showing cells in relation to particles of
pigment. H. & E. x 325.
FIG. 10.-Intramuscular CdS: Gross appearance of tumour in thigh and pelvis.
FIG. 11. Intramuscular CdS: Pleomorphic sarcoma. H. & E. x 325.
FIG. 12. Intramuscular CdS: Tumour tissue infiltrating muscle of thigh. H. & E. x 325.
FIG. 13.-Intramuscular CdS: Fibrosis in muscle in a rat which did not develop a tumour.
H.&E. x 190.
FIG. 14. Subcutaneous CdO: Pleomorphic sarcoma. H. & E. x 325.
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the serosal surface being breached at one point, close to the attachment of the
diaphragm. Enlarged hard glands were seen in the coeliac region and at the apex
of the thoracic cavity. Involvement of the thoracic or abdominal organs was
not apparent. Sectioning of the main tumour mass, which weighed 115 g.,
showed a variegated pink, brown andgrey cut surface with abrightyellowpigment
deposit. In some parts the tumour consisted of moderately well differentiated
spindle cells, with interlacing bundles ofcollagen fibres. In other parts the tumour
was highly cellular, pleomorphic and with numerous bizarre multinucleate giant
cells. Mitoses were frequent and some of these were abnormal. There were
fairly numerous thin-walled blood vessels of sarcomatous type, as well as areas of
haemorrhage and necrosis. Deposits of the injected cadmium sulphide were also
present. The tumour infiltrated striated muscle, adipose and lymphoid tissue.
A lymph node from the coeliac region and a paratracheal node close to the apex
ofthe pleura contained metastases. The appearances ofthe tumour were those of
a spindle-celled and pleomorphic-celled fibrosarcoma. Hyaline droplet degenera-
tion was present in the tubular epithelium of the kidneys and there was a mild
interstitial infiltration with chronic inflammatory cells. Areas of haemorrhage
and degeneration with an inflammatory cell infiltration were seen in the adrenal
glands.
To confirm the above findings, a further 30 rats were injected in the same way
with the same dose of cadmium sulphide. The group contained equal numbers of
males, meanweight 580 g., andfemales, meanweight 360 g., nine months old at the
time of injection. Four rats died in less than six months, the remaining 26 rats
surviving for varying periods up to 21 months from the time of injection. Six
ofthese 26 rats, 4 male and 2 female, developed large tumours at the injection site,
dying between 9 and 19 months after injection (Table I). Grossly, the tumours
TABLE I.-Length of Survival ofEach Rat After Injection, Time in Months unless
otherwise stated. The Rats which Developed Sarcomata are shown with an
asterisk
Survival time after injection
Group , -- - _
Subcutaneous CdSI . . . . 8 8 8 10* 10* 11* 11* 11* 11* 12
Subcutaneous CdSlI . . . . 2 4 5 5 7 7 8 8 8 8
8 9 9 9 9* 10* 10 10 11* 11
11 12 13* 14 14 15 15 17* 19* 21
Subcutaneous CdS . . . . . 1 1 2 3 4 7 10 15 24 31
(serial sacrifice) day day days days days days days days days days
3 6 6 7* 11
Intramuscular CdS . . . 5 7 7 9 10* 12* 12 13* 13* 14
15* 15 16* 17
Subcutaneous CdO . . . . 5 5 6* 7* 7* 8 10* 11* 12* 12
were similar to those already described, and microscopic examination showed
them all to be spindle-celled fibrosarcomata, some more cellular than others,
although there was less pleomorphism than in the tumours in the first group. In
addition 2 rats developed fibroadenosis of the breast and in one rat (Rat 17) a
mammary adenocarcinoma was present. These 3 animals also presented with
swellings in the flank but the situation, appearance and histological features ofthe
tumours were very different to those related to the injection site which have
already been described.
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The yield of sarcomata of 230% in this second group of rats was considerably
lower than the 60 / incidence in the original group of ten rats. The rats in the
larger group were 3 months older when injected and the cadmium sulphide had
been prepared afresh, but the conditions were otherwise apparently similar.
However, this difference in tumour incidence may have been a chance effect, due
to the small number of animals involved. (X2 =292, 0 1 > p > 0.05.)
The local tissue reaction to the subcutaneous injection of cadnium sulphide
Fifteen male rats were each given a single injection of25 mg. cadmium sulphide,
suspended in 0X25 ml. physiological saline into the dorsal subcutaneous tissue.
Animals were killed at intervals, starting on the day after injection, an area ofskin
and subcutaneous tissue containing the injection site being excised for examination.
The following observations are based on the examination of sections taken chrono-
logically.
The injected cadmium sulphide was identifiable in the sections as a deposit
which appeared dark in the centre ofthe mass, with golden yellow particles towards
the periphery. The deposit was situated in the subcutaneous areolar connective
tissue either deep to, or else interrupting the continuity of the panniculus carnosus,
a narrow band of striped muscle found in this region. The first section, made a
few hours after injection, showed the mass of injected material in relation to the
subcutaneous structures without any appreciable tissue reaction. Twenty-four
hours after injection an acute inflammatory reaction had developed characterised
by a neutrophil polymorphonuclear leucocytic response close to the deposit.
Trhere were no fibroblasts to be seen at this stage. Particles of the injected pig-
ment were seen in the perivascular lymphatics and in phagocytes. Forty-eight
hours after injection the acute inflammatory reaction appeared more widespread
with a marked polymorphonuclear response (Fig. 6). Some of these cells were
seen within the main mass of the deposit of cadmium sulphide. Some fibroblasts
were seen. Lymphatic pathways were outlined by particles of pigment which
radiated from the injected mass in a parallel plane to the skin surface forming a
lacework pattern. After 3 days large fibroblasts had appeared in the area showing
the acute inflammatory response, but few collagen fibres were present. These,
however, were first seen in appreciable numbers 4 days after injection at the
periphery of the deposit, where fibroblasts were more in evidence (Fig. 7). The
acute inflammatory reaction was still prominent at this stage. By the seventh
day the inflammatory reaction was less marked, whilst the fibroblastic prolifera-
tion and collagenous deposition had become more pronounced. A light fibrous
tissue capsule round the mass ofpigment was evident by the tenth day. (A small
abscess was also present at the injection site in the animal killed on the tenth day).
Intracellular pigment particles were seen in a reactive lymph node draining the
injected area. Extensive fibrosis had occurred around the deposit of cadmium
sulphide 3 months after injection (Fig. 8), the fibrous tissue forming a poorly
cellular capsule. Collagen fibres were interwoven between smaller collections of
pigment, which was more widely dispersed than in some other specimens. There
was still evidence of a chronic inflammatory reaction, which was also present
6 months after injection. Two rats survived more than 6 months. One of these,
which died 7 months after injection, developed a large tumour at the injection site
showing the characteristics of a pleomorphic-celled fibrosarcoma (Fig. 9) with
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metastatic deposits in the regional lymph nodes. The last animal died 11 months
after injection. The injected pigment was surrounded by a dense collagenous
capsule with almost no cellular reaction, the appearances being those of late
fibrous scarring.
Induction of sarcoma at the site of intramuscular injection of cadmium sulphide
In this experiment, 14 rats were each given a single dose of 50 mg. cadmium
sulphide suspended in 0-5 ml. physiological saline by deep intramuscular injection
into the lateral aspect of the thigh. Equal numbers of male and female animals
were used, 8 months old at the time of the injection, the male rats weighing
between 445 g. and 520 g. and the female rats between 300 g. and 375 g.
No untoward effects followed the injection. The rats were normally active
and there was no visible reaction or palpable swelling at the injection site during
the following weeks. During the first 9 months after injection 4 animals died
without developing tumours. Rat 5 developed a palpable swelling in the thigh
9 months after injection, and the tumour grew rapidly in size until the animal died
one month later (Fig. 10; Table I). Four more rats (No. 6, 8, 9, and 11; Table I)
developed similar large tumours from 12 to 15 months after injection.
The tumours were firm to hard and merged into the surrounding muscle. They
were highly cellular with haemorrhagic and necrotic areas. Their structure was
mainly spindle-celled, with less pleomorphism than was evident in the tumours of
the first subcutaneous injection series. In Rat 6, the cells were more pleomorphic
than in the rest of the group and the tumour was suggestive of a rhabdomyo-
sarcoma (Fig. 11) but no unequivocal cross striations in the neoplastic cells could
be found. In some sections many mitotic figures were seen. Some tumour giant
cells were present, but these were not in large numbers. Infiltration of muscle
and lymphoid tissue was seen with all the tumours, the infiltration of muscle
resulting in the isolation of fragments of muscle fibres surrounded by neoplastic
cells (Fig. 12). While masses of tumour tissue were present in close relation to
abdominal organs, no infiltration of the parenchyma was seen and metastatic
deposits were not seen in the lungs. In all five tumours, the appearances were
those of fibrosarcoma.
Rat 5.-Intramuscular cadmium sulphide series. Ten months after injection
the left thigh was expanded by a 5 x 4 cm. swelling which felt hard to the touch
and which was within the muscle mass. Division of the swelling revealed a fairly
hard, lobulated tumour with a pinky-grey cut surface, in the centre ofwhich was a
bright yellow deposit of cadmium sulphide pigment. Similar tumour tissue was
seen filling the pelvic cavity and infiltrating the retroperitoneal tissues of the
posterior abdominal wall as far as the diaphragm, displacing the adjacent viscera.
A node of tumour tissue was also visible above the diaphragm and metastases
were present in the regional lymph nodes. Microscopic examination showed a
fairly cellular tumour with small areas of necrosis. The tumour was mainly
spindle-celled although pleomorphism was seen in places. The spindle cells
were arranged in strands and interlacing bundles with collagen fibres between
them, and tumour cells infiltrated the adjacent muscle fibres, isolating some of
these into small segments. The appearances were those of a fibrosarcoma.
In Rats 12 and 13 the injected pigment was surrounded by extensive areas of
chronic inflammatory fibrosis, the fibroblastic proliferation being so marked in
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places as to suggest either premalignant or early malignant change. The remain-
ing 7 rats did not develop malignant tumours, the last in the series of 14 dying
17 months after injection. A small hard swelling was palpable at necropsy in
the injected thigh of these animals. In all 7 this swelling contained much of the
injected pigment interspersed and encapsulated by a mass of dense fibrous tissue
(Fig. 13).
Rat 14.-Intramuscular cadmium sulphide series. At necropsy 17 months
after injection a small swelling was palpable in the injected thigh measuring not
more than 2 X 1 cm. Onreflecting the skinthe muscle overthe swelling appeared
normal. The muscle with the swelling was sectioned to reveal a central mass of
yellow pigment set in a waxy-looking matrix. Histological examination showed
fairly finely divided pigment deposits intersected and surrounded by dense colla-
genous tissue, with an associated chronic inflammatory reaction extending into
the adjacent muscle, both lymphocytes and plasma cells being numerous.
Induction of sarcoma at site of subcutaneous injection of cadmium oxide
Twenty-five mg. cadmium oxide suspended in 0-25 ml. physiological saline
was injected into the dorsal subcutaneous tissue on either side of the midline in
10 three-month old female rats with a mean weight of 280 g., range 230-325 g.
One week after injection, a red, oedematous, indurated area 2 to 3 cm. in diameter
had developed at the injection site. During the following week there was an
exudation of serous fluid, which dried and formed a crusty mass over the inflamed
area. After a further week ulcers had formed at the injection site in 4 of the 10
rats, hard crusts being present on the skin of the remaining 6 animals. One
month after injection the skin surface had ulcerated in 8 of the 10 rats, the ulcers
discharging serous fluid which contained brown particles of the injected cadmium
oxide. Healing occurred slowly over the succeeding 4 to 6 weeks with the forma-
tion of crusts which later separated. The skin at the site of injection eventually
regained its normal appearance, although palpation revealed it to be tethered
to the subcutaneous tissues.
Four months after injection a swelling developed at the injection site in one
of the rats, which grew slowly at first and then rapidly. Over the succeediiig
8 months large tumours had developed at the injection site in 8 ofthe 10 animals.
The length of survival of each animal after injection is shown in Table I, where
it can be seen that there were no survivors after one year. Six rats died and 4,
all of which bore large fungating tumours, were killed when they appeared to be
ill. The skin over the tumour ulcerated in each case, but in one animal (Rat 7)
an ulcer developed at an early stage, the tumour appearing to grow beneath the
edge of this ulcer. The tumours were firm to hard in consistency and were
coarsely lobulated, the largest one measuring 8 x 6 cm. Each tumour had
infiltrated the body wall, and the lobulated surface was visible from the pleural
and peritoneal aspects, in some cases compressing or displacing the viscera. The
tumours also grew in the direction of the axilla, and in 5 animals (Rats 3, 5, 7, 8,
9) enlarged, hard nodes were present in the axilla. The cut surface ofthe tumours
had a variegated grey-pink colour, and in one (Rat 8) a cystic space was encoun-
tered.
Microscopic examination revealed the presence of tumours having the charac-
teristics ofspindle-celled or pleomorphic-celled fibrosarcoma in 6 ofthe 10 injected
animals (Rats 3, 4, 5, 7, 8 and 9). In the remaining 2 rats with tumours (No. 2
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and 10) the tissues were mislaid and nohistological examination could beperformed.
Some ofthe tumours were more vascular than others, and some contained necrotic
areas. Two of the tumours (Rats 7 and 9) were moderately well differentiated,
plump spindle cells being arranged in strands with collagen fibres between them.
The other tumours (Rats 3, 4, 5 and 8) contained similar collections of spindle
cells as well as numerous pleomorphic cells with scanty or no intercellular material
(Fig. 14). Tumour giant cells were present, and there were some large bizarre
cells, each with a deeply staining nucleus and a large amount ofcytoplasm. Many
mitotic figures were seen, some of which were abnormal. In all cases tumour
cells were seen to be infiltrating the muscle fibres and subcutaneous connective
tissue. No visceral metastases were seen. In their gross and microscopic
appearances, with the pleomorphism of the cells and the presence of areas with
spindle cells and intercellular collagen, the tumours resembled closely those
obtained in the series of rats inijected with cadmium sulphide.
Control series
A group of 10 three-month old rats was injected in the same way with 0-25 ml.
physiological saline into the dorsal subcutaneous tissue on either side of the
midline. No nodules or tumours developed at the injection sites over the course
of one year's observation in any of these animals. Similarly no tumours were
observed arising spontaneously from the subcutaneous tissue of the dorsal region
or of the flank, other than mammary gland tumours, in any of a large number of
rats used in other experiments and observed for periods exceeding one year.
DISCUSSION
A number of animal experiments with cadmium salts given by moutl, by
inhalation or by injection has been reported, but in most of these the period of
observation has been too short for a carcinogenic effect to become apparent.
The feeding of rats with diets containing up to 0-05/0 cadmium as the chloride
for up to 150 days was not reported to give rise to malignant disease (Wilson,
DeEds and Cox, 1941). The inhalation of cadmium sulphide and cadmium oxide
dusts did not result in significant abnormalities in two groups of 10 dogs respec-
tively after one year's exposure (Princi and Geever, 1950). Repeated intra-
peritoneal injections of cadmnium chloride were made in rats at a rate of 2-25 mg.
per kg. per week for 6 months and in some cases this was followed by 0 75 mg.
per kg. per week for a further 6 months (Bonnell, Ross ar,d King, 1960). Fourteen
rats were observed for a period ofone year but no neoplastic changes were reported.
On the other hand, cadmium metal (Heath and Daniel, 1964), cadmium sulphate
(Haddow et al., 1964; Gunn et al., 1964), cadmium sulphide and cadmium oxide
have given rise to malignant tumours at the site of subcutaneous or intramuscular
injection in the rat. In addition, interstitial cell tumours of the testis have
followed subcutaneous injection of cadmium sulphate (Roe et al., 1964). It
appears therefore that cadmium is a carcinogenic metal in the rat under certain
specified conditions.
With an insoluble compound like cadmium sulphide it may be questioned
whether the cadmium sulphide itself, the cadmium ion or a more soluble salt or
complex acts as the carcinogen, or whether a physical action is involved rather
than a chemical one, dependent on the introduction ofa mass ofinsoluble material
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into the subcutaneous tissues. Cadmium sulphide is virtually insoluble in water,
but some may be converted into a more soluble compound in the tissues. It is
possible that an effective carcinogenic dose may be attained by cadmium in a
soluble form released from the cadmium sulphide particles in the vicinity of
susceptible cells for an adequate period to induce the neoplastic change. Similar
considerations could also apply to cadmium oxide.
The carcinogenic action of a compound is not related to its ability to produce
fibrosis, as is well illustrated by the action of silica. However, the implantation
of inert films and foils in the subcutaneous tissues has given rise to sarcomata
originating from the fibrous tissue capsule surrounding the implant (Oppen-
heimer, Oppenheimer, Stout, Willhite and Danishefsky, 1958). Inert powders
have been much less effective than foils in producing this effect (Oppenheimer,
Oppenheimer, Danishefsky, Stout and Eirich, 1955), but nevertheless it is difficult
to attribute a carcinogenic effect to chemical factors alone in experiments where
local tumours have followed the subcutaneous injection of insoluble materials.
However, tumours have developed after intramuscular injection of cadmium and
of cadmium sulphide and interstitial cell tumours of the testis have followed
subcutaneous injection of cadmium sulphate.
Other relatively insoluble metallic sulphides and oxides have been injected
subcutaneously, but only some of these have shown a carcinogenic effect. Thus
Gilman (1962) produced malignant tumours with nickel sulphide and its oxide
and with cobalt sulphide and its oxide, but failed to obtain tumours with iron or
copper sulphides and oxides. In an experiment with nickel sulphide, the present
authors (unpublished data) obtained fibrosarcomata at the injection site in 8 of a
group of 10 rats injected subcutaneously with 25 mg. nickel sulphide in each of
two sites as already described. In similar experiments, the subcutaneous injec-
tion of arsenic sulphide gave rise to two sarcomata, ferrous sulphide to one
sarcoma and ferric sulphide to one sarcoma in groups of ten rats injected respec-
tively with each compound. The sulphides oflead and zinc, and barium sulphate,
another insoluble metallic compound, did not give rise to tumours in similar
groups of 10 rats injected with each compound in the same way. It thus appears
likely that some factor other than that related to the physical presence of a
relatively inert powder in the subcutaneous tissues was necessary to give rise to
tumours in these experiments.
Gilman (1962) and Heath and Daniel (1964) identified the majority of their
tumours in rats as rhabdomyosarcomata, whilst Gunn et al. (1964) described
pleomorphic sarcomata and Haddow et al. (1964) described their tumours as
sarcomata or as spindle-celled sarcomata. In the present series, no clear evidence
was found that any of the tumours was of rhabdomyomatous nature. Many of
the rats in the present series were females, but unfortunately the testes of those
male rats which were used were not examined histologically. No testicular
tumours were seen with the naked eye, however, on routine necropsy examination.
SUMMARY
The introduction of cadmium sulphide into the subcutaneous tissue of the rat
h1as been shown to give rise to an inflammatory reaction followed by fibrosis in the
vicinity of the injected particles. Sarcomata developed later at the site of injec-
tion in a number of the animals. Post-inflammatory fibrosis with, in a number
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of cases, the later development of sarcoma was also observed following intra-
muscular injection of the compound. The subcutaneous inijection of cadmium
oxide was followed by a more intense inflammatory reaction with ulceration of the
overlying skin. After healing had occurred, and the passage of a latent interval
similar to that for cadmium sulphide, sarcomatous change was again observed in
a proportion of the animals injected.
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